Chad’s revenue grows, but losses persist
CHATSWORTH, Calif. - Chad Therapeutics said domestic sales of its oxygen conservers jumped 22% last year, boosting the company’s share in a market it pioneered in the 1980s. Although sales of its Total O2 Delivery System declined in the quarter ending March 31, Chad blamed that slide on the loss of one of the transfilling concentrator’s big customers. That customer had been purchased by a national chain that doesn’t use the Total O2. Chad says that October 2001 acquisition will no longer impact sales trends for the Total O2. In the recently concluded fourth quarter, Chad realized revenue gains of 13% to $4.7 million but a net loss for the quarter of $841,000. For the year, the company’s sales climbed 3%, but it lost $433,000 on the year. Of that loss, $165,000 represented expenditures incurred when a group of “dissident” shareholders tried unsuccessfully to elect nominees to the company’s board.
Trac’s parent sells more, loses less, wins financing
SCHENECTADY, N.Y. - The business segment of Authentidate Holding Corp. that includes e-CMN mover, Trac Medical, boosted sales to $1.1 million for the first nine months of its current fiscal year. That’s up from $41,704 over the same period in the previous year. The same group tallied $4.1 million losses over those nine months. Two weeks after reporting these 9-month results, Authentidate announced that it had completed a private financing of approximately $2.7 million.
In June, Invacare Supply Group released its 234-page home care catalog, including 500 new products in expanded sections for respiratory, incontinence, wound care, DME, diabetic and orthopedics...Hans Rudolph has just received FDA 510(k) clearance on its new V.I.P. 7500 Series NIV full-face mask as a multi-patient, multi-use, reusable face mask for non-invasive ventilation in the home, hospital or other clinical settings.